ClinConnect ClinConnect Logo
Search / Trial NCT06082362

Personalized Signature of Chronic Inflammation and Early Aging Predictive of the Comorbidities in Infertile Men

Launched by IRCCS SAN RAFFAELE · Oct 9, 2023

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Infertility Male Infertility Comorbidity Andrology Immuno Epidemiology Environmental Factors Genetic Factors

ClinConnect Summary

This clinical trial is studying male infertility, specifically looking at how chronic inflammation and early aging might be linked to other health issues in infertile men. The researchers aim to find new biological markers that can help predict and prevent serious health problems, like tumors, in men who are struggling with infertility. By understanding these connections better, they hope to create personalized treatment plans to support men's health.

To be eligible for this trial, participants need to be men aged 18 to 50 who identify as White and have been diagnosed with certain types of infertility. They should be able to give their consent to participate. Men who have secondary infertility, a history of blood-related diseases, or have taken antibiotics in the last six months will not be able to participate. Those who join the study can expect to undergo tests that will help researchers gather important information about their health and infertility. It's a chance to contribute to valuable research that could lead to better understanding and treatment options for men facing infertility challenges.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Age \> 18 and \< 50 years;
  • White race
  • Men with OAT o iNOA infertility diagnosis
  • ability to sign the consent information
  • Exclusion Criteria:
  • inability to sign the consent information
  • secondary infertility diagnosis
  • history of hematological diseases
  • people treated with antibiotics in the six months prior the enrollment

About Irccs San Raffaele

IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.

Locations

Milan, Lombardy, Italy

Patients applied

0 patients applied

Trial Officials

Andrea Salonia, MD

Principal Investigator

IRCCS Ospedale San Raffaele

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported